GlassScriptPhysician profile
Frank W W Virgin
NPI 1821207002
$938.38
in general payments reported to CMS, 2019-2025
4 companies · $418 in 2025
The $418 reported for 2025 was more than what 76% of Pediatric Otolaryngology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2022: $151 · 2023: $145 · 2024: $68.02 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $581 · Travel and Lodging: $50.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $581.12 |
| Travel and Lodging | $50.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $564.59 | 2022-2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Advanced Bionics, LLC | $156.39 | 2019 | |
| Inspire Medical Systems, INC. | $149.38 | 2025 | Inspire |
| Integra Lifesciences Corporation | $68.02 | 2024 | Relieva Spinplus Nav, Acclarent Aera, Inspira Air |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank W Virgin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.